Keros Therapeutics
Healthcare & Life Sci
Company overview
Keros Therapeutics is a biopharmaceutical company developing therapies that target disorders related to transforming growth factor-beta (TGF-beta) signaling. It aims to create disease-modifying treatments for patients with unmet medical needs. Its product candidates, KER-050 and KER-065, are in development for neuromuscular and hematology disorders.
Keros Therapeutics has a partnership with Takeda Pharmaceutical Company, a link to a large pharmaceutical partner that can matter for a smaller biotech's funding and stability. Keros Therapeutics is an H-1B sponsor.
- Industry
- Healthcare & Life Sci
- Headquarters
- Lexington, United States